SLRN

ACELYRIN, INC.

4.33 USD
+0.15 (+3.59%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

ACELYRIN, INC. stock is down -6.48% since 30 days ago. The next earnings date is Aug 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 100% of the previous 1 June’s closed higher than May. 100% of analysts rate it a buy.

About ACELYRIN, INC.

ACELYRIN is a late-stage clinical biopharma company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. Our principal executive offices are located at 4149 Liberty Canyon Road, Agoura Hills, California.